Todd Denton Gould is an American psychiatrist and associate professor of psychiatry at the University of Maryland School of Medicine. He earned his MD from the University of Virginia, after which he completed a research fellowship at the National Institute of Mental Health's Laboratory of Molecular Pathophysiology and Experimental Therapeutics.[1] His research has shed light on the pharmacological mechanism by which ketamine-related drugs are able to treat depression in mice.[2][3][4]

References

  1. ↑ "Gould, Todd". University of Maryland School of Medicine. Retrieved 2019-04-29.
  2. ↑ Morrison, Joanne (2019-03-27). "UMSOM Researchers Discover a Critical Receptor Involved in the Response to Fast-Acting Antidepressants Like Ketamine". University of Maryland School of Medicine. Retrieved 2019-04-29.
  3. ↑ Swetlitz, Ike (2016-05-04). "How ketamine eases depression — and why that matters for pharma". STAT. Retrieved 2019-04-29.
  4. ↑ Simon, Matt (2019-04-11). "Lasers Highlight Ketamine's Depression-Fighting Secrets". Wired. ISSN 1059-1028. Retrieved 2019-04-29.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.